Groop PH et al. Excess Mortality in Patients With type 1 Diabetes Without Albuminuria-Separating the Contribution of Early and Late Risks. Diabetes Care 2018 Jan 29. pii: dc171618. doi: 10.2337/dc17-1618. [Epub ahead of print] Si la prise en charge du diabète de type 1 s’est nettement améliorée ces dernières années, les données sur la […]
Charleer S et al. Accuracy and precision of flash glucose monitoring sensors inserted into the abdomen and upper thigh compared with the upper arm Diabetes Obes Metab. 2018 Jan 30. doi: 10.1111/dom.13239 Depuis le remboursement du système Free style libre ® (FSL) de lecture flash de la glycémie, la plupart des patients diabétiques sous […]
Lalau JD et al. Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4. Diabetes Care 2018 Jan 5. pii: dc172231. 10.2337/dc17-2231. [Epub ahead of print]. Dans toutes les recommandations et prises de position d’experts, la metformine (MET) reste le traitement de première intention dans le diabète […]
Kaarsholm NC, et al. Engineering glucose responsiveness into insulin. Diabetes 2018 Feb;67(2):299-308. doi: 10.2337/db17-0577 Qui n’a jamais rêvé un jour de disposer d’une insuline qui, une fois injectée, modulerait sa capacité à réduire la glycémie en fonction de la concentration en glucose circulant ? Cela représenterait une réelle sécurité pour nos patients ! En […]
Pearson-Stuttard J, Zhou B, et al. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment Lancet Diabetes Endocrinology 2018;6(2):95-104. doi: 10.1016/S2213 8587(17)30366-2 Si cela fait plus de 30 ans que l’excès pondéral est reconnu comme un facteur favorisant le développement de certains cancers, le diabète l’est également depuis […]
Salminen P et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA 2018 Jan 16; 319 :241-254. doi: 10.1001/jama.2017.20313 Il y a eu un grand changement ces dernières décennies dans le choix des techniques de […]
Dunn T et al. Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests. Diabetes Res Clin Pract 2017;137:37-46. doi: 10.1016/j.diabres.2017.12.015 Voilà maintenant plus de 6 mois que le FreeStyle Libre® (FSL), premier système FGM (Flash Glucose Monitoring) disponible, a fait irruption […]
Parvanova A, et al. Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial. Lancet Diabetes Endocrinol 2018 Jan;6(1):27-40. doi: 10.1016/S2213-8587(17)30359-5 La néphropathie diabétique constitue la principale cause d’insuffisance rénale terminale dans le monde et touche environ 35% des patients diabétiques (1). L’albuminurie […]
Jakubowicz D, et al. Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial. Diabetes Care 2017;40:1573-1579. doi: 10.2337/dc16-2753 L’équipe du Professeur Froy, de l’Institut de biochimie de l’Université hébraïque de Jérusalem a montré il y a quelques années que l’horloge circadienne contrôle […]
Triebswetter S et al. Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes, Am J Nephrol. 2018; 47 : 30-39. doi: 10.1159/000485842 L’insuffisance rénale chronique terminale et le recours à l’hémodialyse concernaient en 2010 un total de 2,6 millions de personnes dans le monde. En 2030, ce chiffre atteindra plus de 5,4 millions […]
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
